Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
Pheochromocytomas and paragangliomas (PCC/PGLs) are rare, mostly catecholamine-producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal paraganglia (PGL). They can be separated into three different molecular clusters depending on their underlying gene mutations in any of the...
Main Authors: | Nölting, S, Ullrich, M, Pietzsch, J, Ziegler, C, Eisenhofer, G, Grossman, A, Pacak, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
MDPI
2019
|
Similar Items
-
Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
by: Svenja Nölting, et al.
Published: (2019-10-01) -
Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
by: Nölting, S, et al.
Published: (2012) -
Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas
by: Gildas Gabiache, et al.
Published: (2023-09-01) -
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
by: Karel Pacak, et al.
Published: (2019-09-01) -
Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background
by: Martin Ullrich, et al.
Published: (2019-05-01)